MOLECULAR ANALYSIS OF MUTATIONS IN A PATIENT WITH PURINE NUCLEOSIDE PHOSPHORYLASE-DEFICIENCY

被引:0
作者
AUST, MR
ANDREWS, LG
BARRETT, MJ
NORBYSLYCORD, CJ
MARKERT, ML
机构
[1] DUKE UNIV,MED CTR,DEPT PEDIAT,BOX 3068,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,DURHAM,NC 27710
[3] SUNNYSIDE HOSP,DEPT ALLERGY & IMMUNOL,CLACKAMAS,OR
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purine nucleoside phosphorylase (PNP) deficiency is an inherited autosomal recessive disorder resulting in severe combined immunodeficiency. The purpose of this study was to determine the molecular defects responsible for PNP deficiency in one such patient. The patient's PNP cDNA was amplified by PCR and sequenced. Point mutations leading to amino acid substitutions were found in both alleles. One point mutation led to a Ser-to-Gly substitution at amino acid 51 and was common to both alleles. In addition, a Asp-to-Gly substitution at amino acid 128 and an Arg-to-Pro substitution at amino acid 234 were found in the maternal and paternal alleles, respectively. In order to prove that these mutations were responsible for the disease state, each of the three mutations was constructed separately by site-directed mutagenesis of th normal PNP cDNA, and each was transiently expressed in COS cells. Lysates from cells transfected with the allele carrying the substitution at amino acid 51 retained both function and immunoreactivity. Lysates fro cel s transfected with PNP alleles carrying a substitution at either amino acid 128 or am no acid 234 contain immunoreactive material but had no detectable human PNP activity. In summary, molecular analysis of this patient identified point mutations within the PNP gene which are responsible for the enzyme deficiency.
引用
收藏
页码:763 / 772
页数:10
相关论文
共 52 条
[1]  
AGARWAL RP, 1969, J BIOL CHEM, V244, P644
[2]   IMMUNOTHERAPY AND IMMUNOPATHOLOGIC STUDIES IN A PATIENT WITH NUCLEOSIDE PHOSPHORYLASE DEFICIENCY [J].
AMMANN, AJ ;
WARA, DW ;
ALLEN, T .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1978, 10 (03) :262-269
[3]  
ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856
[4]  
AVIS H, 1972, P NATL ACAD SCI USA, V69, P1408
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]  
CARAPELLADELUCA E, 1978, J PEDIATR-US, V93, P1000
[7]   LYMPHO-SPECIFIC TOXICITY IN ADENOSINE-DEAMINASE DEFICIENCY AND PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY - POSSIBLE ROLE OF NUCLEOSIDE KINASE(S) [J].
CARSON, DA ;
KAYE, J ;
SEEGMILLER, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) :5677-5681
[8]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[9]  
COOPER DN, 1990, HUM GENET, V85, P55
[10]   THE CPG DINUCLEOTIDE AND HUMAN GENETIC-DISEASE [J].
COOPER, DN ;
YOUSSOUFIAN, H .
HUMAN GENETICS, 1988, 78 (02) :151-155